Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04726514 · ClinicalTrials.gov registry record · NA

SleepFlexTM Treatment of Obstructive Sleep Apnea

A NA study of Obstructive Sleep Apnea, sponsored by Berendo Scientific.

Completed
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT04726514 is a NA study of Obstructive Sleep Apnea that has completed, run by Berendo Scientific. The registered enrollment target is 10 participants, below the 222-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04726514, a NA study of Obstructive Sleep Apnea, has completed, sponsored by Berendo Scientific.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the safety and effectiveness of the SleepFlex program for treatment of mild to moderate OSA

Conditions Studied

Interventions

  • DEVICE SleepFlex

Study Locations (1)

California

  • Tower Sleep Medicine - Los Angeles

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2021-07-20
Est. Completion 2022-05-31
Phase NA

Sponsor

Berendo Scientific

1 total trials

What the Registry Record Tells You About NCT04726514

The ClinicalTrials.gov registry entry for NCT04726514 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 222-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (95% lower). The listed sponsor is Berendo Scientific, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which SleepFlex is the first listed.

NCT04726514 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04726514 about?

NCT04726514 is a clinical study titled "SleepFlexTM Treatment of Obstructive Sleep Apnea". The purpose of this study is to evaluate the safety and effectiveness of the SleepFlex program for treatment of mild to moderate OSA

What is the current status of trial NCT04726514?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2021-07-20. Estimated completion is 2022-05-31.

What conditions does trial NCT04726514 study?

This clinical trial studies the following conditions: Obstructive Sleep Apnea.

What interventions are being tested in trial NCT04726514?

The interventions under investigation include: SleepFlex (DEVICE).

Who is sponsoring clinical trial NCT04726514?

This trial is sponsored by Berendo Scientific, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04726514 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obstructive Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.